Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease

American Journal of Pathology

Volumn 152, Issue 6, 1998, Pages 1633-1640

  Funato, Hiromasa ^a,b   Yoshimura, Masahiro ^c   Kusui, Kaoru ^a   Tamaoka, Akira ^d   Ishikawa, Kin'ya ^d   Ohkoshi, Norio ^d   Namekata, Kazuhiko ^a   Okeda, Riki ^b   Ihara, Yasuo ^a,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Tokyo Medical Examiner's Office   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TRANSFERRIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL MODIFICATION; ENZYME IMMUNOASSAY; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; CEREBRAL CORTEX; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSFERRIN;

EID: 0031781795     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL: A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 1988, 38:1688-1693
2. Selkoe DJ: Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 1994, 53:438-447
3. Mori H, Takio K, Ogawara M, Selkoe DJ: Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem 1992, 267:17082-17086
4. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD: Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993, 268:3072-3083
5. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 1994, 13:45-53
6. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Amyloid β-protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down's syndrome. Ann Neurol 1995, 37:294-299
7. Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T: Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease: predominance of Aβ42(43) and association of Aβ40 with cored plaques. Am J Pathol 1996, 148:259-265
8. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG: An increased percentage of long amyloid β-protein is secreted by familial amyloid β-protein precursor (βAPP717) mutants. Science 1994, 264:1336-1340
9. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S: Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713
10. Tomita T, Maruyama K, Saido TC, Kume H, Shinozaki K, Tokuhiro S, Capell A, Walter J, Grunberg J, Haass C, Iwatsubo T, Obata K: The presenilin 2 mutation (N141l) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc Natl Acad Sci USA 1997, 94:2025-2030
11. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259
12. Hamano T, Shinkai Y, Yanagisawa K, Yoshimura M, Yamazaki T, Kuriyama M, Ihara Y: Amyloid β-protein (Aβ) accumulation in the leptomeninges during aging and in Alzheimer's disease. J Neuropathol Exp Neurol 1997, 56:922-932
13. Tierney MC, Fisher H, Lewis AJ: The NINCDS-ADRDA Work group criteria for the clinical diagnosis of probable Alzheimer's disease: clinicopathological study of 57 cases. Neurology 1988, 38:356-364
14. Mirra SS, Heyman A, McKee D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, participating CERAD neuropathologists: The Consortium to Establish a Registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 42:1681-1688
15. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y: Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995, 38:421-428
16. Shinkai Y, Yoshimura M, Morishima-Kawashima M, Ito Y, Shimada H, Yanagisawa K, Ihara Y: Amyloid β-protein deposition in the leptomeninges and cerebral cortex. Ann Neurol 1997, 42:899-908
17. Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N: Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 1995, 34:10272-10278
18. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG: Amyloid β protein (Aβ) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 1995, 270:7013-7016
19. Yanagisawa K, Odaka A, Suzuki N, Ihara Y: GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature Med 1995, 1:1062-1066
20. Tamaoka A, Odaka A, Ishibashi Y, Usami M, Sahara N. Suzuki N, Nukina N, Mizusawa H, Shoji S, Kanazawa I, Mori H: APP 717 mis-sense mutation affects the ratio of amyloid β protein species (Aβ1-42(43) and Aβ1-40) in familial Alzheimer's disease brain. J Biol Chem 1995, 269:32721-32724
21. Roher AE, Chaney MO, Kuo Y-M, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR: Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 1996, 271:20631-20635
22. Hyman BT, Marzloff K, Arriagada PV: The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 1993, 52:594-600
23. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990, 31:545-548
24. Namekata K, Oyama F, Imagawa M, Ihara Y: Human transferrin (Tf): a single mutation at codon 570 determines Tf C1 or Tf C2 variant. Hum Genet 1997, 100:457-458
25. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:9649-9653
26. Rebeck GW, Reiter JS, Strickland DK, Hyman BT: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993, 11:575-580
27. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K: Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995. 333:1242-1247
28. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K: A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993, 163: 166-168
29. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, Hamaguchi H: Dose-dependent association of apolipoprotein E allele ε4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994, 36:656-659
30. Namekata K, Imagawa M, Terashi A, Ohta S, Oyama F, Ihara Y: Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum Genet 1997, 101:126-129
31. Nakanaga M, Yasuda T, Tenjo E, Nadano D, Fujiki N, Kishi K: Transferrin polymorphisms in Japanese population: North-South cline in the distribution of the TF*C2 allele. Hum Biol 1991, 63:187-195
32. Nakabayashi J, Yoshimura M, Morishima-Kawashima M, Funato H, Miyakawa T, Yamazaki T, Ihara Y: Amyloid β-protein (Aβ) accumulation in the putamen and mammillary body during aging and in Alzheimer disease. J Neuropathol Exp Neurol 1998, 57:343-352
33. Gearing M, Mori H, Mirra SS: Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 1997, 39:395-399
34. Ishii K, Tamaoka A, Mizusawa H, Shoji S, Ohtake T, Fraser PE, Takahashi H, Tsuji S, Gearing M, Mizutani T, Yamada S, Kato M, St George-Hyslop PH, Mirra SS, Mori H: Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E ε4 allele dosage in sporadic Alzheimer's disease. Brain Res 1997, 748:250-252
35. Lue LF, Brachova L, Civin WH, Rogers J: Inflammation, Aε deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996, 55: 1083-1088
36. Wisniewski HM, Vorbrodt AW, Wegiel J: Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease. Ann NY Acad Sci 1997, 826:161-172
37. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE: Water-soluble Aε (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 1996, 271:4077-4081
38. Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, Ball MJ: Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 1994, 269:10987-10990
39. Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L: Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 1997, 94:1550-1555
40. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S: Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci Lett 1996, 215:173-176